BidaskClub downgraded shares of ICU Medical, Incorporated (NASDAQ:ICUI) from a hold rating to a sell rating in a research note issued to investors on Thursday.

ICUI has been the topic of several other research reports. Zacks Investment Research raised ICU Medical, from a hold rating to a strong-buy rating and set a $195.00 price objective on the stock in a report on Wednesday, July 12th. Roth Capital downgraded ICU Medical, from a buy rating to a neutral rating in a research note on Thursday, May 11th. They noted that the move was a valuation call. Gabelli reissued a buy rating on shares of ICU Medical, in a research note on Friday, August 11th. Finally, Sidoti downgraded ICU Medical, from a buy rating to a neutral rating in a research note on Tuesday, June 20th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. ICU Medical, presently has a consensus rating of Hold and an average target price of $193.00.

ICU Medical, (NASDAQ:ICUI) traded up 1.13% during mid-day trading on Thursday, reaching $169.85. The company’s stock had a trading volume of 198,033 shares. ICU Medical, has a 1-year low of $120.15 and a 1-year high of $176.50. The firm has a 50 day moving average price of $170.97 and a 200-day moving average price of $161.01. The company has a market capitalization of $3.37 billion, a PE ratio of 68.02 and a beta of 0.37.

ICU Medical, (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.06. ICU Medical, had a negative return on equity of 13.14% and a negative net margin of 11.18%. The firm had revenue of $331.51 million for the quarter, compared to analyst estimates of $318.30 million. During the same period in the prior year, the company posted $1.15 EPS. The firm’s quarterly revenue was up 242.8% compared to the same quarter last year. On average, equities analysts predict that ICU Medical, will post $4.11 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “BidaskClub Lowers ICU Medical, Incorporated (ICUI) to Sell” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.thecerbatgem.com/2017/08/27/bidaskclub-lowers-icu-medical-incorporated-icui-to-sell.html.

In related news, Director Robert S. Swinney sold 4,477 shares of the company’s stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $175.00, for a total value of $783,475.00. Following the completion of the sale, the director now owns 23,293 shares in the company, valued at approximately $4,076,275. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Chairman Vivek Jain sold 100,000 shares of the company’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $170.80, for a total transaction of $17,080,000.00. Following the completion of the sale, the chairman now owns 110,925 shares of the company’s stock, valued at approximately $18,945,990. The disclosure for this sale can be found here. In the last three months, insiders sold 203,965 shares of company stock worth $34,856,920. 15.90% of the stock is currently owned by company insiders.

Hedge funds have recently added to or reduced their stakes in the stock. Creative Planning boosted its stake in ICU Medical, by 315.6% in the first quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 505 shares in the last quarter. Louisiana State Employees Retirement System boosted its stake in ICU Medical, by 1.7% in the first quarter. Louisiana State Employees Retirement System now owns 6,000 shares of the medical instruments supplier’s stock worth $916,000 after buying an additional 100 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in ICU Medical, by 2.5% in the first quarter. State of Alaska Department of Revenue now owns 1,640 shares of the medical instruments supplier’s stock worth $250,000 after buying an additional 40 shares in the last quarter. Glen Harbor Capital Management LLC boosted its stake in ICU Medical, by 1.4% in the first quarter. Glen Harbor Capital Management LLC now owns 4,004 shares of the medical instruments supplier’s stock worth $612,000 after buying an additional 56 shares in the last quarter. Finally, First Mercantile Trust Co. boosted its stake in ICU Medical, by 37.4% in the first quarter. First Mercantile Trust Co. now owns 3,490 shares of the medical instruments supplier’s stock worth $533,000 after buying an additional 950 shares in the last quarter. Institutional investors and hedge funds own 77.10% of the company’s stock.

About ICU Medical,

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Receive News & Stock Ratings for ICU Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Incorporated and related stocks with our FREE daily email newsletter.